Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

infusion

infusion is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 6
Pipeline programs 1,046
News articles 0
Drug details — infusion
Class
—
Route
—
Patents
6
Programs
1046
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

infusion is an FDA-listed pharmaceutical active ingredient.

Key facts

INN infusion

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 000434 Phase 3 · Ferring Pharmaceuticals · High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-mu
  2. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  3. 1001 Phase 3 · Biotest Farmaceutica Ltda · Non-severe community-acquired pneumonia (CAP) or moderate or
  4. 1438-0011 Phase 3 · Boehringer Ingelheim · advanced or metastatic extrapulmonary neuroendocrine carcino
  5. 1438-0012 Phase 3 · Boehringer Ingelheim · small cell lung cancer
  6. 1479-0008 Phase 3 · Boehringer Ingelheim · non-squamous non-small cell lung cancer
  7. 1479-0032 Phase 3 · Boehringer Ingelheim · Non-small cell lung cancer
  8. 17000139BLC3001 Phase 3 · Janssen-Cilag International N.V · Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder

Related patents

Browse patents

  1. US 11904052

    Methods for ameliorating infusion reactions

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11351118

    Methods for ameliorating infusion reactions

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10736975

    Infusion administration of conjugated monoclonal antibodies

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10632255

    Drug infusion device

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9480669

    Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. DE 102004006048

    Pharmazeutische Kombination aus Gadolinium Komplexen und kolloidalen Biopolymeren und deren Verwendung als kontrastverstärkendes Mittel zur i.v. Injektion bzw. i.v. Infusion in der MR Angiographie

    Expires Wed Aug 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is infusion?

infusion is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.